Microbot Medical Inc. MBOT Income Statement

Microbot medical inc. (MBOT)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenue from product sales
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	831	810	784	662	646	536	0	0	0
Revenue from licensing agreements
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	-	-88	172	0	0	0	-	1,698	1,657	1,643	1,220	932	953	0	0	0
Revenue from licensing agreements, grants and other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	177	185	192	489	866	847	858	557	286	416	0	0	0
Cost of product sales
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	255	244	232	214	203	167	0	0	0
Gross profit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	1,442	1,413	1,410	1,005	729	785	0	0	0
Research and development
3,152	3,048	2,820	2,600	2,606	2,515	2,104	1,820	1,412	1,100	2,366	1,687	1,304	901	-14,972	-14,617	-7,334	-823	-482	3,898	2,499	836	19,681	20,469	19,434	19,368	18,069	16,363	15,307	14,682	15,999	17,045	18,350	19,937	20,304	20,638	0	0	0
General and administrative
4,335	4,192	4,516	4,698	5,039	4,729	4,620	4,386	4,137	4,167	12,020	10,819	9,849	8,734	-5,304	-4,984	-2,847	-92	-1,426	624	704	251	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, general and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7,203	7,129	7,323	7,359	7,626	7,723	8,050	8,202	7,930	8,483	0	0	0
Wind-down expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	61	218	373	344	356	228	142	247	287	384	0	0	-	0
Total operating expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	29,780	30,213	28,656	28,264	25,491	23,865	22,974	22,398	24,508	25,565	27,303	29,082	28,493	29,437	0	0	0
Operating loss
-7,487	-7,240	-7,336	-7,298	-7,645	-7,244	3,810	4,328	4,985	5,267	-13,096	-12,506	-11,153	-9,635	18,935	19,550	10,160	915	1,830	-4,519	-3,206	-1,087	-30,139	-30,415	-28,677	-28,092	-25,290	-23,711	-22,839	-21,908	-23,066	-24,152	-25,892	-28,076	-27,763	-28,652	0	0	0
Financing expenses, net
-100	-103	-167	-89	-94	-16	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Financing income (expenses), net
-	-	-	-	-	-	-	-	-	-	-2,288	113	111	28	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Realized gain on sale of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-2,922	1,296	-3,115	-3,253	10,813	4,464	0	-	0	0	-	-	-	-	-	-	-
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	7,727	8,471	0	0	0
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	8	6	6	11	14	17	18	15	12	13	16	13	22	32	0	0	0
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	1,416	1,487	1,537	1,166	795	424	45	50	54	59	65	71	78	87	0	0	0
Other income (expense), net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-38	-41	-39	8	-100	-101	-98	-83	27	183	158	109	339	207	0	0	0
Total other income (expense), net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	1,476	-2,818	1,544	2,106	3,574	-7,149	-1,318	-6,062	-9,878	3,210	81	6,747	8,094	8,707	0	0	0
Net loss from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-7,491	-7,247	-7,503	-7,387	-7,739	-7,260	0	0	0	-	-12,252	-11,717	-10,694	-9,663	15,836	16,451	8,153	-921	3,436	716	-2,937	-1,206	-29,455	-33,889	-27,642	-26,439	-22,235	-31,380	-24,678	-28,491	-32,944	-20,942	-25,810	-21,328	-19,669	-19,945	0	0	0
Basic and diluted net loss per share from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.04	-0.22	-0.14	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic and diluted net loss per share from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic and diluted net loss per share
-0.31	-0.42	-0.44	-0.36	-0.48	-0.65	-0.60	-0.66	-0.50	-1.90	-0.45	-0.45	0.04	-5.84	-0.08	-0.01	-0.01	2.73	-0.00	-1.07	-1.62	0.24	-0.04	-0.22	-0.14	-0.12	-0.17	-0.15	-0.17	-0.03	-0.54	0.03	-0.45	-0.48	-0.31	-0.29	-0.42	-0.44	-0.38
Basic and diluted weighted average common shares outstanding
7,154	4,367	4,307	4,307	4,086	3,050	2,947	2,855	2,763	-23,263	2,383	2,383	27,212	-	-	-	-	-	7,541	7,932	5,768	12,573	66,535	55,711	55,343	54,359	41,402	39,661	38,263	37,363	30,168	24,806	22,958	15,259	14,009	13,802	13,679	12,709	11,990